ROW Foundation is a 501(c)(3) private foundation working to improve the quality of care for persons living with epilepsy and associated psychiatric disorders in under-resourced areas of the world. Since its start in 2015, ROW Foundation has established 81 partnerships in 37 countries and made cumulative grants in excess of $22 million, including the distribution of more than 192,000 prescription months of anti-seizure medication to those who otherwise would go without.
Together with ROW Global Health and OWP Pharmaceuticals, ROW Foundation forms a pharmaceutical social enterprise intent on promoting health equity around the world.